Lacosamide Injection Is Used To Treat Partial-Onset Seizures, As Well As Primary Generalised Tonic-Clonic Seizures When Combined With Other Medications. Zydus Lifesciences Ltd, Has Received Final Approval From The United States Food And Drug Administration (Usfda) To Market Lacosamide Injection Usp, 200 Mg/20 Ml (10 Mg/Ml) Single-Dose Vials (Us Rld: Vimpat). Lacosamide Injection Is Used To Treat Partial-Onset Seizures. It Is Also Used With Other Medicines To Treat Primary Generalised Tonic-Clonic Seizures. It Acts On The Central Nervous System (Cns) To Reduce The Number And Severity Of Seizures. The Drug Will Be Manufactured At The Group
